Ochy

"Get personalised, lab-quality running gait analysis in under 60 seconds with any camera. No lab. No hardware. No equipment." [1]

Where it wins

• Democratizes access to biomechanical analysis by replacing expensive treadmill-based hardware with a standard smartphone camera [2].
• Provides actionable, research-backed corrective exercises tailored to individual morphology and running habits, not just raw data [1].
• Trusted by major athletic federations (French Athletics Federation, England Athletics) and integrated into the global adidas adiClub loyalty program [1][3].
• Bridges the gap between consumer fitness and clinical rehabilitation by serving both runners and health professionals like physiotherapists [4].

Credibility: Claims are supported by the company's homepage detailing the technology and partnerships, and Pulse 2.0's report on the adidas integration and funding [1][3].

• AI-Driven SaaS: The core product is a software platform that processes video uploads to generate biomechanical insights, enabling scalable delivery without physical hardware [4].
• Data and Algorithm Proprietary: Revenue is driven by a proprietary pose estimation algorithm specifically designed for running, underpinned by 200+ peer-reviewed studies [1].
• Hybrid Go-to-Market: Combines direct-to-consumer mobile app access with strategic B2B partnerships (athletic federations, retail, clinical) to drive adoption and credibility [1][4].
• Value Unit: The unit of value is the 'insight' or 'analysis report' generated in under 60 seconds, which includes metrics (cadence, ground contact time) and corrective exercises [1].

• Traditional Motion Labs: Expensive, hardware-heavy, and inaccessible to the mass market [2].
• Wearable Sensors: Devices like Stryd or Garmin provide data but lack the visual, form-correction focus of Ochy [1].
• Other AI Gait Apps: Competitors like Najar (ex Welii) and Lokki offer similar video analysis, but Ochy differentiates with its scientific backing and B2B partnerships [5].
• Physical Therapy Clinics: Traditional clinics offer analysis but are location-bound and expensive [1].
• Differentiators: Ochy's unique value lies in its combination of lab-grade accuracy, smartphone accessibility, specific running focus, and strong B2B2C partnerships (adidas, federations) [1][3][2].

• Inaccessibility of Lab Analysis: Runners lack access to affordable, lab-quality biomechanical analysis without expensive hardware [2].
• Injury Prevention: Runners suffer from injuries due to improper form, which could be corrected with better analysis [3].
• Lack of Actionable Feedback: Existing tools often provide data without specific, research-backed corrective exercises [1].
• Professional Tool Gap: Physiotherapists and coaches lack accessible, objective tools for remote or in-clinic gait analysis [1].

Ochy's integration with adidas adiClub is a significant wedge, providing access to a massive, engaged user base and validating the product in a consumer context. The transition from B2C to B2B2C via retail and clinical partnerships de-risks revenue and builds a moat through professional endorsement. The main risk is the scalability of the AI model across diverse running environments and the potential for competition from larger tech players entering the health-tech space. The next signal to watch is the expansion of the Runners Need partnership beyond the UK and the adoption rate of the clinical version by physiotherapists.

Expand the B2B2C model by targeting more global retail partners beyond the UK to accelerate user acquisition and brand visibility. Develop a more robust B2B sales motion for the clinical version, targeting larger hospital networks and sports medicine clinics to drive higher-value contracts. Enhance the community features within the app to leverage user-generated content and social sharing, driving organic growth. Consider exploring data monetization opportunities, such as anonymized biomechanical data insights for research or product development in the sports equipment industry, while maintaining strict privacy standards.